Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular

Status Recruiting

Clinical Trial Summary

Application Management Team:

PI - Siu Wai Choi; email - htswchoi@hku.hk Delegates - Chui Shan Chu; email: sunshine.c@connect.hku.hk FollowUpUsers - Chui Shan Chu; email:sunshine.c@connect.hku.hk

Clinical Trial Description

Eligibility Criteria:

- patients were diagnosed with a baseline disease of oral squamous carcinoma.

Exclusion Criteria:

- N/A

Sample size:

- ~500 subjects

Source of Data:

- The data, such as age and medical records, would be obtained from Hospital Authority Clinical Management System (HACMS)

Statistical analysis:

- machine learning will be applied into analysis plan ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04543266
Study type	Observational
Source	The University of Hong Kong
Contact	SW Choi, PhD
Phone	+85228590390
Email	htswchoi@hku.hk
Status	Recruiting
Phase
Start date	September 7, 2020
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06438939` - NBI for Early Diagnosis of OPMD/OSCC	N/A
Recruiting	`NCT05024383` - Dissecting the Heterogeneity of Oral Cancer Pain	N/A
Recruiting	`NCT06031337` - Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
Not yet recruiting	`NCT06174428` - Validity of Viome's Oral/Throat Cancer Test
Recruiting	`NCT05098119` - Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)	Phase 2
Recruiting	`NCT05069857` - Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients	Phase 2
Not yet recruiting	`NCT03619304` - Assessment of Anti-cancerous Effect of Green, Roasted and Decaffeinated Coffee on Oral Squamous Cell Carcinoma Cell Line	N/A
Active, not recruiting	`NCT01772706` - Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck Cancer	N/A
Recruiting	`NCT05893888` - Safety and Efficacy Study of PRV211 in Subjects With Oral Squamous Cell Carcinoma	Phase 1/Phase 2
Recruiting	`NCT05125055` - Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC	Phase 2/Phase 3
Not yet recruiting	`NCT06055868` - People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
Not yet recruiting	`NCT06130007` - A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma.	Phase 2
Recruiting	`NCT05798793` - Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma	Phase 3
Recruiting	`NCT02739204` - Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma	Phase 2
Completed	`NCT05708209` - The Long Non Coding MALAT1 as a Potential Salivary Diagnostic Biomarker in Oral Squamous Cell Carcinoma Through Targeting mi RNA 124
Recruiting	`NCT05862168` - Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial	Phase 2
Recruiting	`NCT05451303` - Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Recruiting	`NCT05902455` - Differential Mobility Spectrometry (DMS) Based Oral Tumor Analysis
Not yet recruiting	`NCT05803915` - Neoadjuvant Toripalimab Plus Nimotuzumab in Oral Squamous Cell Carcinoma Prior to Radical Therapy	Phase 2
Recruiting	`NCT05791149` - Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity	N/A

Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms